URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

James Mason

Concepts (348)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Telomere
12
2002
27
4.610
Why?
Drosophila melanogaster
10
2002
63
3.370
Why?
Hypertension
7
2003
301
2.240
Why?
Drosophila Proteins
5
2002
82
2.040
Why?
Drosophila
3
2004
80
1.530
Why?
DNA Breaks, Double-Stranded
2
2009
23
1.420
Why?
Retroelements
6
2003
30
1.190
Why?
DNA-Binding Proteins
3
2008
685
1.110
Why?
Chromosomal Proteins, Non-Histone
4
2002
16
1.090
Why?
Diabetes Mellitus
4
2003
169
1.080
Why?
Pancreatitis
2
2007
29
0.870
Why?
Life Style
5
2004
85
0.860
Why?
Gene Silencing
4
2003
41
0.780
Why?
Wound Healing
5
2003
206
0.780
Why?
Practice Guidelines as Topic
4
2004
302
0.750
Why?
Heterochromatin
3
2002
17
0.750
Why?
Evidence-Based Medicine
5
2002
202
0.730
Why?
DNA Transposable Elements
3
2002
42
0.720
Why?
Chromosomes
3
2005
38
0.700
Why?
Cost-Benefit Analysis
4
2004
215
0.630
Why?
Relaxation Therapy
1
2008
16
0.620
Why?
Animals
21
2001
16093
0.610
Why?
Hyperlipidemias
2
2003
45
0.600
Why?
Antihypertensive Agents
2
2004
79
0.580
Why?
Terminal Repeat Sequences
2
2003
6
0.570
Why?
Diabetes Mellitus, Experimental
2
2003
79
0.570
Why?
Severity of Illness Index
1
2010
922
0.550
Why?
Diabetes Complications
3
2003
66
0.540
Why?
Economics, Pharmaceutical
1
2006
6
0.540
Why?
Meta-Analysis as Topic
1
2006
36
0.530
Why?
Sodium Chloride Symporter Inhibitors
1
2005
10
0.530
Why?
Euchromatin
1
2005
1
0.520
Why?
Flavoproteins
1
2004
6
0.490
Why?
Adrenergic beta-Antagonists
1
2005
174
0.490
Why?
Amino Acid Oxidoreductases
1
2004
39
0.490
Why?
Diabetic Angiopathies
1
2005
34
0.480
Why?
Lysosomes
1
2004
53
0.480
Why?
Transduction, Genetic
2
2003
124
0.460
Why?
Femur Head Necrosis
1
2003
4
0.460
Why?
Cementation
1
2003
16
0.460
Why?
Transcription, Genetic
2
2007
812
0.460
Why?
Bone Cements
1
2003
15
0.450
Why?
Hip Prosthesis
1
2003
40
0.450
Why?
Cold Temperature
1
2003
98
0.450
Why?
Humans
32
2002
36274
0.440
Why?
Arthroplasty, Replacement, Hip
1
2003
45
0.440
Why?
Health Care Costs
1
2004
113
0.440
Why?
Leukocytes
1
2004
189
0.430
Why?
Hot Temperature
1
2003
164
0.430
Why?
Transgenes
4
2003
72
0.420
Why?
Mutation
4
2002
1216
0.420
Why?
Models, Biological
2
2003
1008
0.410
Why?
Gene Products, gag
1
2002
17
0.400
Why?
Transforming Growth Factor beta
2
2001
412
0.400
Why?
Immediate-Early Proteins
1
2001
32
0.390
Why?
Collagen Type I
1
2001
49
0.390
Why?
Growth Substances
1
2001
102
0.380
Why?
Intercellular Signaling Peptides and Proteins
1
2001
111
0.370
Why?
DNA Repair
3
2009
172
0.360
Why?
Cell Cycle
3
2009
254
0.360
Why?
Extracellular Matrix
1
2001
162
0.350
Why?
RNA, Messenger
2
2001
1863
0.330
Why?
Chromosome Mapping
3
2002
227
0.320
Why?
Base Sequence
4
2003
1683
0.310
Why?
Models, Genetic
3
2003
161
0.300
Why?
Antioxidants
2
2007
205
0.300
Why?
England
5
2002
45
0.300
Why?
Randomized Controlled Trials as Topic
4
2005
411
0.300
Why?
Meiosis
2
2004
27
0.290
Why?
Animals, Genetically Modified
2
2003
54
0.270
Why?
Molecular Sequence Data
3
2003
1988
0.270
Why?
Telephone
2
2005
20
0.250
Why?
Two-Hybrid System Techniques
2
2011
67
0.250
Why?
Immunoprecipitation
2
2011
81
0.250
Why?
Proto-Oncogene Proteins c-sis
2
2003
21
0.240
Why?
Specialties, Nursing
2
2003
3
0.240
Why?
Blood Pressure
3
2003
467
0.240
Why?
Judgment
2
2005
14
0.240
Why?
Female
14
2002
19838
0.240
Why?
Male
17
2002
19675
0.230
Why?
Blotting, Southern
2
2002
99
0.230
Why?
Ambulatory Care
2
2005
156
0.230
Why?
APACHE
2
2007
31
0.220
Why?
Trans-Activators
2
2003
365
0.220
Why?
Research Design
2
2012
336
0.220
Why?
Pancreatitis, Alcoholic
1
2012
1
0.210
Why?
Quality of Life
4
2006
502
0.210
Why?
Pancreatitis, Chronic
1
2012
2
0.210
Why?
Pyoderma Gangrenosum
1
2012
1
0.210
Why?
Prednisolone
1
2012
24
0.210
Why?
Diabetes Mellitus, Type 2
2
2005
224
0.200
Why?
Dermatologic Agents
1
2012
24
0.200
Why?
Cellulitis
1
2011
11
0.200
Why?
Leg Dermatoses
1
2011
6
0.200
Why?
Middle Aged
10
2003
9837
0.200
Why?
Cyclosporine
1
2012
64
0.200
Why?
Penicillin V
1
2011
27
0.200
Why?
Transfection
2
2004
859
0.200
Why?
Opioid-Related Disorders
1
2011
25
0.200
Why?
Aged
9
2003
7269
0.190
Why?
Governing Board
1
2011
2
0.190
Why?
Acute Disease
2
2007
586
0.190
Why?
State Medicine
1
2011
17
0.190
Why?
Preventive Medicine
1
2011
34
0.190
Why?
Mice
6
2001
6111
0.190
Why?
Venous Thrombosis
1
2011
80
0.190
Why?
Protein Structure, Tertiary
2
2008
347
0.180
Why?
Area Under Curve
1
2010
63
0.180
Why?
Aged, 80 and over
4
2005
2529
0.180
Why?
DNA-(Apurinic or Apyrimidinic Site) Lyase
1
2010
13
0.180
Why?
Physicians
1
2012
157
0.180
Why?
Heart Failure
2
2002
367
0.170
Why?
Adult
8
2005
11351
0.170
Why?
Genes, Insect
1
2009
7
0.170
Why?
Gene Expression Regulation
2
2003
888
0.170
Why?
Adult Stem Cells
1
2009
22
0.160
Why?
Delivery of Health Care
1
2011
146
0.160
Why?
Lentivirus
2
2005
25
0.160
Why?
Bone Regeneration
1
2009
38
0.160
Why?
Health Policy
2
2005
78
0.160
Why?
Glioma
1
2010
102
0.160
Why?
Pain
1
2012
382
0.160
Why?
Adrenal Cortex Hormones
1
2009
96
0.160
Why?
Psoriasis
1
2009
47
0.160
Why?
Bone Density Conservation Agents
1
2009
51
0.160
Why?
Species Specificity
1
2009
341
0.160
Why?
Skull
1
2009
126
0.160
Why?
Vitamin D
1
2009
71
0.160
Why?
Oocytes
1
2009
135
0.150
Why?
Drug Therapy, Combination
2
2005
382
0.150
Why?
Mutagenesis, Insertional
1
2008
53
0.150
Why?
Repetitive Sequences, Nucleic Acid
1
2008
79
0.150
Why?
Dermis
2
2003
7
0.150
Why?
Evolution, Molecular
1
2008
67
0.150
Why?
Anti-Bacterial Agents
1
2011
437
0.150
Why?
Sequence Homology
1
2007
15
0.150
Why?
Chromatin
1
2008
99
0.150
Why?
Pyruvate Kinase
1
2007
25
0.150
Why?
Treatment Outcome
6
2003
2615
0.140
Why?
Histones
1
2009
174
0.140
Why?
Group Processes
1
2006
16
0.140
Why?
Arsenicals
1
2006
6
0.140
Why?
Fertility
1
2006
49
0.140
Why?
Longevity
1
2006
27
0.140
Why?
Diet, Sodium-Restricted
1
2006
13
0.140
Why?
Review Literature as Topic
1
2006
8
0.140
Why?
Pancreatic Neoplasms
1
2007
82
0.140
Why?
Phenotype
1
2009
763
0.140
Why?
Oxides
1
2006
21
0.140
Why?
Polymerase Chain Reaction
2
2003
596
0.140
Why?
Internationality
1
2006
26
0.130
Why?
Hydrogen-Ion Concentration
2
2004
566
0.130
Why?
Social Support
2
2005
227
0.130
Why?
Primary Health Care
1
2011
487
0.130
Why?
Femur
2
2003
86
0.130
Why?
Gene Components
1
2005
2
0.130
Why?
Oligonucleotide Array Sequence Analysis
1
2008
286
0.130
Why?
Genomic Library
1
2005
14
0.130
Why?
Genes, sis
1
2005
1
0.130
Why?
Insurance, Health, Reimbursement
1
2006
28
0.130
Why?
Models, Economic
1
2006
28
0.130
Why?
Repressor Proteins
1
2008
176
0.130
Why?
Risk Factors
3
2005
2345
0.130
Why?
Apoptosis
1
2011
823
0.130
Why?
Physician's Practice Patterns
2
2002
243
0.130
Why?
Nuclear Proteins
1
2009
335
0.130
Why?
Pigmentation
1
2004
5
0.120
Why?
Microscopy, Electron
1
2005
377
0.120
Why?
4-Aminobenzoic Acid
1
2004
1
0.120
Why?
Amino Acids, Aromatic
1
2004
2
0.120
Why?
Benzoic Acid
1
2004
3
0.120
Why?
L-Amino Acid Oxidase
1
2004
3
0.120
Why?
NIH 3T3 Cells
1
2004
24
0.120
Why?
Computational Biology
1
2005
67
0.120
Why?
Sequence Analysis, DNA
1
2005
166
0.120
Why?
Cost Allocation
1
2004
2
0.120
Why?
HMGB1 Protein
1
2004
2
0.120
Why?
Fractures, Bone
1
2005
95
0.120
Why?
In Situ Hybridization
1
2005
323
0.120
Why?
Myelodysplastic Syndromes
1
2006
131
0.120
Why?
Health Care Rationing
1
2004
6
0.120
Why?
Adolescent
2
2010
4766
0.120
Why?
Mice, Inbred C57BL
3
2003
1675
0.120
Why?
Cell Line
1
2009
1585
0.120
Why?
Subcellular Fractions
1
2004
96
0.120
Why?
Genetic Markers
1
2004
134
0.120
Why?
Eye
1
2004
55
0.120
Why?
Gastroenterology
1
2004
10
0.120
Why?
Osteoporosis
1
2005
85
0.120
Why?
Binding, Competitive
1
2004
198
0.120
Why?
DNA Primers
1
2005
403
0.120
Why?
Quality-Adjusted Life Years
1
2004
53
0.120
Why?
Promoter Regions, Genetic
1
2007
553
0.120
Why?
Substrate Specificity
1
2004
230
0.120
Why?
Finite Element Analysis
1
2003
11
0.110
Why?
Patient-Centered Care
1
2005
76
0.110
Why?
Health Services Research
1
2004
118
0.110
Why?
Immunohistochemistry
2
2003
1064
0.110
Why?
Double-Blind Method
3
2007
992
0.110
Why?
Oxidation-Reduction
1
2004
304
0.110
Why?
Retroviridae
1
2003
73
0.110
Why?
Recombination, Genetic
1
2004
176
0.110
Why?
Eye Color
1
2003
1
0.110
Why?
Equipment Failure Analysis
1
2003
71
0.110
Why?
Blood Glucose
1
2005
464
0.110
Why?
Prosthesis Failure
1
2003
86
0.110
Why?
Periosteum
1
2003
23
0.110
Why?
Pharmacists
1
2002
6
0.110
Why?
Models, Chemical
1
2003
103
0.110
Why?
Temperature
1
2003
242
0.110
Why?
Patient Satisfaction
1
2005
226
0.110
Why?
Drug Utilization
1
2002
48
0.100
Why?
Enzyme Inhibitors
1
2004
422
0.100
Why?
Anaphase
1
2002
3
0.100
Why?
Metaphase
1
2002
9
0.100
Why?
Genes, Reporter
1
2003
208
0.100
Why?
Insect Proteins
1
2002
10
0.100
Why?
Education, Medical, Continuing
1
2002
64
0.100
Why?
Macrophages
1
2004
346
0.100
Why?
Algorithms
1
2006
541
0.100
Why?
Left-Right Determination Factors
1
2001
1
0.100
Why?
Connective Tissue Growth Factor
1
2001
2
0.100
Why?
Guideline Adherence
1
2002
83
0.100
Why?
Genes, Dominant
1
2002
79
0.100
Why?
DNA Probes
1
2002
88
0.100
Why?
Cartilage, Articular
1
2003
208
0.100
Why?
Fibrosarcoma
1
2001
33
0.100
Why?
Recombinant Proteins
1
2004
723
0.100
Why?
Matrix Metalloproteinases
1
2001
35
0.100
Why?
Mitosis
1
2002
99
0.100
Why?
Kinetics
1
2004
1391
0.100
Why?
Stem Cell Transplantation
1
2003
110
0.100
Why?
Computer Simulation
1
2003
302
0.100
Why?
Mice, Nude
1
2001
183
0.090
Why?
Family Practice
1
2002
181
0.090
Why?
Transcriptional Activation
1
2003
285
0.090
Why?
Antineoplastic Agents
1
2006
619
0.090
Why?
Polymorphism, Genetic
1
2002
201
0.090
Why?
Fibroblasts
1
2003
534
0.090
Why?
Prospective Studies
3
2006
1689
0.090
Why?
Recurrence
2
2011
691
0.090
Why?
Great Britain
2
2006
97
0.080
Why?
Risk Assessment
3
2005
884
0.080
Why?
Program Evaluation
3
2003
206
0.080
Why?
Protein Binding
2
2008
827
0.070
Why?
Young Adult
2
2011
1059
0.070
Why?
Infusions, Intravenous
2
2006
143
0.070
Why?
Drug Administration Schedule
2
2006
366
0.060
Why?
Time Factors
2
2012
3182
0.060
Why?
Survival Analysis
2
2006
606
0.060
Why?
Questionnaires
2
2005
1004
0.060
Why?
Exercise
2
2005
182
0.060
Why?
Quality Assurance, Health Care
2
2004
123
0.060
Why?
Prognosis
2
2006
1083
0.050
Why?
Genetic Vectors
2
2005
339
0.050
Why?
Retrospective Studies
2
2007
2267
0.050
Why?
Ireland
1
2012
8
0.050
Why?
Drug Costs
1
2012
25
0.050
Why?
Uncertainty
1
2012
19
0.050
Why?
Leg Ulcer
1
2011
6
0.050
Why?
Costs and Cost Analysis
1
2011
90
0.050
Why?
Medication Adherence
1
2011
21
0.050
Why?
Organizational Case Studies
1
2011
10
0.050
Why?
Antibiotic Prophylaxis
1
2011
34
0.050
Why?
Decision Making, Organizational
1
2011
7
0.050
Why?
Administration, Oral
1
2012
308
0.050
Why?
Qualitative Research
1
2011
53
0.050
Why?
Focus Groups
1
2011
67
0.050
Why?
Heparin
1
2011
122
0.050
Why?
Pain Measurement
1
2012
246
0.050
Why?
Patient Selection
1
2012
212
0.050
Why?
Lucanthone
1
2010
1
0.040
Why?
Anticoagulants
1
2011
135
0.040
Why?
Cells, Cultured
2
2003
2479
0.040
Why?
Prevalence
1
2011
562
0.040
Why?
Biomedical Engineering
1
2009
14
0.040
Why?
Motivation
1
2011
156
0.040
Why?
Radiation Tolerance
1
2010
89
0.040
Why?
Indoles
1
2010
101
0.040
Why?
Incidence
1
2011
685
0.040
Why?
Administration, Topical
1
2009
89
0.040
Why?
Micrococcal Nuclease
1
2008
14
0.040
Why?
RNA, Small Interfering
1
2010
192
0.040
Why?
Hospitalization
1
2011
399
0.040
Why?
DNA Damage
1
2010
170
0.040
Why?
Nucleosomes
1
2008
80
0.040
Why?
Selenium
1
2007
38
0.040
Why?
Cell Line, Tumor
1
2010
575
0.040
Why?
Ascorbic Acid
1
2007
50
0.040
Why?
Chronic Disease
1
2009
522
0.040
Why?
Acetylcysteine
1
2007
78
0.040
Why?
Brain Neoplasms
1
2010
281
0.030
Why?
Ovary
1
2006
91
0.030
Why?
Hematologic Diseases
1
2006
39
0.030
Why?
Fish Oils
1
2006
9
0.030
Why?
Gene Expression
1
2010
751
0.030
Why?
Administrative Personnel
1
2006
22
0.030
Why?
Calcium, Dietary
1
2006
20
0.030
Why?
Rats, Sprague-Dawley
1
2009
986
0.030
Why?
Disease-Free Survival
1
2006
198
0.030
Why?
Azo Compounds
1
2005
18
0.030
Why?
Data Interpretation, Statistical
1
2006
157
0.030
Why?
Antigens, CD31
1
2005
18
0.030
Why?
Sunlight
1
2005
15
0.030
Why?
Magnesium
1
2006
131
0.030
Why?
Consensus
1
2005
14
0.030
Why?
Coloring Agents
1
2005
53
0.030
Why?
Comprehension
1
2005
26
0.030
Why?
Staining and Labeling
1
2005
162
0.030
Why?
Mice, Inbred Strains
1
2005
245
0.030
Why?
Hemoglobin A, Glycosylated
1
2005
50
0.030
Why?
Tumor Markers, Biological
1
2007
229
0.030
Why?
Immunoenzyme Techniques
1
2005
220
0.030
Why?
Potassium
1
2006
304
0.030
Why?
Tumor Necrosis Factors
1
2004
15
0.030
Why?
Green Fluorescent Proteins
1
2005
213
0.030
Why?
Diet
1
2006
204
0.030
Why?
Cricetulus
1
2004
92
0.030
Why?
Software
1
2005
125
0.030
Why?
Mice, Inbred C3H
1
2004
236
0.030
Why?
CHO Cells
1
2004
182
0.030
Why?
DNA, Bacterial
1
2004
173
0.030
Why?
Patient Compliance
1
2005
174
0.030
Why?
Pilot Projects
1
2005
442
0.030
Why?
Ambulatory Care Facilities
1
2003
33
0.030
Why?
Oxidative Stress
1
2007
346
0.030
Why?
Bone Morphogenetic Protein 7
1
2003
7
0.030
Why?
Cricetinae
1
2004
366
0.030
Why?
Cholesterol
1
2003
137
0.030
Why?
Lipopolysaccharides
1
2004
211
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
542
0.030
Why?
Hedgehog Proteins
1
2003
55
0.030
Why?
Intervention Studies
1
2002
31
0.030
Why?
Analysis of Variance
1
2005
736
0.030
Why?
Organizational Innovation
1
2002
28
0.030
Why?
Knee Joint
1
2003
55
0.030
Why?
Community-Institutional Relations
1
2002
29
0.030
Why?
Tissue Engineering
1
2003
86
0.020
Why?
Bone Morphogenetic Proteins
1
2003
189
0.020
Why?
Osteoarthritis
1
2002
148
0.020
Why?
Rabbits
1
2003
697
0.020
Why?
Rats
1
2009
4289
0.020
Why?
Disease Models, Animal
1
2005
956
0.020
Why?
Escherichia coli
1
2004
520
0.020
Why?
Cytokines
1
2004
565
0.020
Why?
Follow-Up Studies
1
2005
1855
0.020
Why?
Depressive Disorder
1
2002
318
0.020
Why?
Cardiovascular Diseases
1
2002
277
0.020
Why?

Visualizations


Mason's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department